Bivalirudin dosing study for children having heart procedures
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at how the blood-thinner bivalirudin moves through the body in children during certain heart procedures. It may help doctors choose safer, more accurate dosing for pediatric anticoagulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old
- Your weight must be more than 3 kilograms
- You are scheduled for a heart procedure such as cardiac catheterization, heart surgery using a heart-lung machine (CPB), or other outside-the-body support (extracorporeal support)
- Your treatment plan already calls for you to receive bivalirudin
- You should not have kidney failure that requires dialysis or another kidney replacement treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
This study tests whether a blood thinner called bivalirudin, given during a procedure to open blocked heart arteries (PCI), helps blood flow better in the tiny vessels of the heart afterward. It is for people with a recent unstable heart condition and a high-risk plaque seen on a CT scan.
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
This study tests a blood thinner called rivaroxaban in children who have a blood clot inside the heart. The goal is to see if it safely and effectively dissolves the clot, potentially avoiding the need for stronger treatments.
This study compares two blood-thinning medicines used during a heart procedure (PCI) after you've already received clot-busting drugs. The goal is to see which one helps prevent more blockages and complications.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
Hear when a new Drug Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.